June 2019
·
27 Reads
·
1 Citation
Acta Medica
Objective: Interferon alpha therapy is associated with series of adverse effects leading premature discontinuation of treatment. Here we aimed to determine the effects of Tumor necrosis alpha promoter polymorphisms on in-terferon related side effects during interferon alpha 2b treatment in chronic hepatitis B patients. Material and Methods: This observational study enrolled 50 chronic hepatitis B patients, who were treated with interferon alpha 2b 10 tiw plus lamivu-dine 100mg/day at were followed-up with complete blood count, transaminases and amylase monthly at out patient clinics of our department. All patients were asked to fill a questionnaire to evaluate the interferon related side effects at every visit. Tumor necrosis factor alpha-238 and-308 polymorphisms were investigated with PCR-Restriction fragment length polymorphisms. Results: Arthralgia was present in 93.8% of patients. Exhaustion, loss of appetite , mount dryness and fever are the leading complaints of the patients. Median complaint scores were 9, 9.5, 11 and 5 at 4 th , 12 th , 24 th and 48 th week visits, respectively. Thrombocytopenia and leucopenia were detected in 8 (16%) and 5 (10%) patients, respectively. One-third of the patients reported depressive mood however, depression was diagnosed in 5 (10%) patients. TNF alpha promoter 238GG and 308GG allele was present in 42/50 and 43/50 patients, respectively. No association was found between TNF promoter allele and certain patient-reported side effect, complaint score, hema-tological and psychological adverse effects. Conclusion: TNF alpha promoter polymorphisms do not contribute to occurrence of IFN alpha treatment related side effects. Keywords: TNF alpha promoter polymorphism, interferon alpha, interferon related side effect, chronic hepatitis B ORIGINAl ARTIClE acta medica